ZHOU Feng

ZHOU Feng has filed trades across 3 companies (mainly through HKEX), most often in Fangzhou Inc., 3D Medicines Inc. and Jin MI Fang Group Holdings Ltd. In total, 26 filings cover trades dated from 3 October 2023 to 28 July 2026.

The open-market side counts 11 purchases for €48k alongside 10 sales for €13.2M. No amount is published for 7 filings, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2026 alone, the filings show 3 purchases and 5 sales.

In size, the median ticket on the buying side is €4,570. On 3 out of 9 purchases, another insider of the same company was buying within the same 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. After 8 purchases with a full 90-day history, the hit rate stands at 75% and the median 90-day move at +14.1%. They describe history only and say nothing certain about the share price ahead.

On 31 July 2026 came the latest disclosure, an open-market purchase for €2,522 in 3D Medicines Inc. Filings reach the HKEX feed a median of 5 days after the trade. This delay matters because a trade only becomes useful information once it is public. Every figure here comes from the filings published by HKEX and describes the past, not future prices; it is not investment advice.